Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management
Singapore medical journal
; : 70-75, 2018.
Artigo
em Inglês
| WPRIM (Pacífico Ocidental)
| ID: wpr-777565
Biblioteca responsável:
WPRO
ABSTRACT
Osteoporosis is a major, growing healthcare issue. This is especially of concern in an ageing population like that of Singapore. Osteoporotic patients are at risk of fractures, which can result in increased morbidity and mortality. The use of antiresorptive therapy with bisphosphonates or denosumab has been proven to reduce fracture risk. However, the use of these medications has rarely been associated with the development of osteonecrosis of the jaw, a potentially debilitating condition affecting one or both jaws. Appropriate understanding of the patient's antiresorptive therapy regime, as well as early institution of preventive dental measures, can play an important role in preventing medication-related osteonecrosis of the jaw (MRONJ). Regular monitoring and prompt referral to specialist care is warranted for patients with established MRONJ.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Doenças do Sistema Endócrino
/
Doenças Musculoesqueléticas e Reumáticas
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Osteonecrose
/
Osteoporose
/
Singapura
/
Doenças Maxilomandibulares
/
Fatores de Risco
/
Resultado do Tratamento
/
Usos Terapêuticos
/
Difosfonatos
/
Tratamento Farmacológico
/
Conservadores da Densidade Óssea
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Limite:
Idoso
/
Humanos
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Singapore medical journal
Ano de publicação:
2018
Tipo de documento:
Artigo